Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Area of Science:

• Clinical Medicine
• Pharmacology
• Dermatology

Background:

• Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is a severe adverse drug reaction requiring careful monitoring.
• Identifying causative agents and tracking disease progression are vital for preventing organ damage in DRESS syndrome.
• The temporal relationship between medications and laboratory abnormalities in DRESS remains understudied.

Purpose of the Study:

• To investigate the association between medication classes and peak serum laboratory values in DRESS syndrome.
• To explore the utility of laboratory data, including aspartate aminotransferase (AST), in monitoring DRESS disease course.
• To determine if vancomycin-triggered DRESS exhibits distinct laboratory patterns.

Main Methods:

• Retrospective analysis of DRESS syndrome cases.
• Utilized simple linear regression to examine relationships between medication class and peak serum levels of absolute eosinophils, creatinine, alanine aminotransferase (ALT), and AST.
• Compared the timing of peak AST values in vancomycin-triggered DRESS versus other drug-triggered DRESS cases.

Main Results:

• A significant difference was observed in the timing of peak aspartate aminotransferase (AST) values in vancomycin-triggered DRESS compared to other DRESS groups.
• This finding suggests a specific role for AST in the context of vancomycin-induced DRESS.
• The study underscores the potential of AST as a valuable monitoring parameter.

Conclusions:

• Aspartate aminotransferase (AST) plays a significant role in the diagnosis and monitoring of DRESS syndrome.
• The timing of peak AST values may differ based on the causative medication, with vancomycin showing a distinct pattern.
• AST monitoring can enhance the management of DRESS syndrome, aiding in the prevention of end-organ damage.